| Q41593086 | A screen for inducers of bHLH activity identifies pitavastatin as a regulator of p21, Rb phosphorylation and E2F target gene expression in pancreatic cancer |
| Q39899359 | Antitumor effects of an imidazoquinoline in renal cell carcinoma |
| Q36035654 | Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice |
| Q42069148 | CAAX-box protein, prenylation process and carcinogenesis |
| Q34598015 | Contemporary epidemiology of renal cell cancer |
| Q84899855 | Do statins reduce patients' risk of hepatocellular carcinoma? |
| Q49855458 | Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials |
| Q38572098 | Exploitation of pleiotropic actions of statins by using tumour-targeted delivery systems. |
| Q39719778 | Fluvastatin increases tyrosinase synthesis induced by alpha-melanocyte-stimulating hormone in B16F10 melanoma cells. |
| Q47657039 | Functional variants in the low-density lipoprotein receptor gene are associated with clear cell renal cell carcinoma susceptibility. |
| Q36366495 | Kidney cancer: identification of novel targets for therapy |
| Q45060115 | Kidney tumors |
| Q40148478 | Lentiviral vector neutral endopeptidase gene transfer suppresses prostate cancer tumor growth |
| Q41080847 | Marketed drugs used for the management of hypercholesterolemia as anticancer armament |
| Q35137857 | Metabolic features of clear-cell renal cell carcinoma: mechanisms and clinical implications |
| Q28477034 | Mevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: a dual role for p53 |
| Q50677481 | Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesis. |
| Q28550876 | Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases |
| Q36810618 | Pilot trial of bone-targeted therapy combining zoledronate with fluvastatin or atorvastatin for patients with metastatic renal cell carcinoma |
| Q34174418 | Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway |
| Q37267573 | Renal and liver tumors in Tsc2(+/-) mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor |
| Q33903747 | STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma |
| Q52578353 | Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. |
| Q36508082 | Statin use and cancer risk: an epidemiologic review |
| Q26864662 | Statin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trials |
| Q35354232 | Statin use and the risk of renal cell carcinoma in 2 prospective US cohorts |
| Q34757109 | Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma |
| Q35186039 | Statin-induced apoptosis via the suppression of ERK1/2 and Akt activation by inhibition of the geranylgeranyl-pyrophosphate biosynthesis in glioblastoma |
| Q39963963 | Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress |
| Q36309420 | Statins improve survival by inhibiting spontaneous metastasis and tumor growth in a mouse melanoma model |
| Q36735614 | Statins inhibit the proliferation and induce cell death of human papilloma virus positive and negative cervical cancer cells |
| Q44677443 | Statins might reduce risk of renal cell carcinoma in humans: case-control study of 500,000 veterans. |
| Q37734257 | Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease |
| Q34206127 | The association between statin medication and progression after surgery for localized renal cell carcinoma |
| Q38499265 | The effect of statins on cancer cells--review |
| Q38211079 | The role of inflammation in kidney cancer |
| Q50225058 | The sensitivity of head and neck carcinoma cells to statins is related to the expression of their Ras expression status, and statin-induced apoptosis is mediated via suppression of the Ras/ERK and Ras/mTOR pathways |